The information requested is not readily available and to provide it would incur disproportionate cost.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4071", "label" : {"_value" : "Biography information for Sarah Newton"} } , "answeringMemberConstituency" : {"_value" : "Truro and Falmouth"} , "answeringMemberPrinted" : {"_value" : "Sarah Newton"} , "dateOfAnswer" : {"_value" : "2018-03-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-03-08T11:51:06.047Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "29"} , "answeringDeptShortName" : {"_value" : "Work and Pensions"} , "answeringDeptSortName" : {"_value" : "Work and Pensions"} , "date" : {"_value" : "2018-03-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Personal Independence Payment"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Work and Pensions, how many completed second or third personal independence payment assessment planned award reviews there have been of people with (a) Parkinson's disease, (b) multiple sclerosis, (c) motor neurone disease, (d) rheumatoid arthritis and (e) cystic fibrosis by year of repeat assessment since the introduction of personal independence payments in 2013; and if she will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1490", "label" : {"_value" : "Biography information for Mrs Madeleine Moon"} } , "tablingMemberConstituency" : {"_value" : "Bridgend"} , "tablingMemberPrinted" : [{"_value" : "Mrs Madeleine Moon"} ], "uin" : "130707"} , {"_about" : "http://data.parliament.uk/resources/853259", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/853259/answer", "answerText" : {"_value" : "
The table below shows the number of people who have been awarded either one or both of the Daily Living and Mobility components at the enhanced rate of Personal Independence Payment (PIP) for awards made between November 1st 2014 and 31st<\/sup> October 2017, where the main disabling condition recorded was Parkinson\u2019s Disease.<\/p> Table 1: Enhanced PIP Daily living and Mobility component awards made between 1st<\/sup> November 2014 and 31st<\/sup> October 2015 with main disabling condition recorded as Parkinson\u2019s Disease.<\/em><\/p> <\/p><\/td> (a) <\/strong>Enhanced Daily Living (may also have Enhanced Mobility)<\/strong><\/p><\/td> (b) <\/strong>Enhanced Mobility (may also have Enhanced Daily Living)<\/strong><\/p><\/td><\/tr> <\/p><\/td> <\/p><\/td> <\/p><\/td><\/tr> Total Awards<\/p><\/td> 1,000<\/p><\/td> 550<\/p><\/td><\/tr> Indefinite Award<\/p><\/td> 180<\/p><\/td> 160<\/p><\/td><\/tr> Finite<\/p><\/td> 820<\/p><\/td> 390<\/p><\/td><\/tr> Of which<\/p><\/td> <\/p><\/td> <\/p><\/td><\/tr> Less than 1 year<\/p><\/td> 70<\/p><\/td> 30<\/p><\/td><\/tr> 1 year<\/p><\/td> 80<\/p><\/td> 30<\/p><\/td><\/tr> 2 years<\/p><\/td> 270<\/p><\/td> 110<\/p><\/td><\/tr> 3 years<\/p><\/td> 230<\/p><\/td> 120<\/p><\/td><\/tr> 4 years<\/p><\/td> 60<\/p><\/td> 30<\/p><\/td><\/tr> 5 years<\/p><\/td> 70<\/p><\/td> 40<\/p><\/td><\/tr> 6 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 7 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 8 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 9 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 10 years<\/p><\/td> 20<\/p><\/td> 40<\/p><\/td><\/tr> 10+ years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> Short Term Award<\/p><\/td> 10<\/p><\/td> 10<\/p><\/td><\/tr><\/tbody><\/table> Source: PIP ADS<\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> <\/p> Table 2: Enhanced PIP Daily living and Mobility component awards made between 1st<\/sup> November 2015 and 31st<\/sup> October 2016 with main disabling condition recorded as Parkinson\u2019s Disease.<\/em><\/p> <\/p><\/td> (a) <\/strong>Enhanced Daily Living (may also have Enhanced Mobility)<\/strong><\/p><\/td> (b) <\/strong>Enhanced Mobility (may also have Enhanced Daily Living)<\/strong><\/p><\/td><\/tr> Total Awards<\/p><\/td> 1,650<\/p><\/td> 1,290<\/p><\/td><\/tr> Indefinite Awards<\/p><\/td> 790<\/p><\/td> 730<\/p><\/td><\/tr> Finite Awards<\/p><\/td> 870<\/p><\/td> 560<\/p><\/td><\/tr> Of which<\/p><\/td> <\/p><\/td> <\/p><\/td><\/tr> Less than 1 year<\/p><\/td> 40<\/p><\/td> 20<\/p><\/td><\/tr> 1 year<\/p><\/td> 60<\/p><\/td> 30<\/p><\/td><\/tr> 2 years<\/p><\/td> 240<\/p><\/td> 120<\/p><\/td><\/tr> 3 years<\/p><\/td> 270<\/p><\/td> 190<\/p><\/td><\/tr> 4 years<\/p><\/td> 80<\/p><\/td> 60<\/p><\/td><\/tr> 5 years<\/p><\/td> 120<\/p><\/td> 100<\/p><\/td><\/tr> 6 years<\/p><\/td> #<\/p><\/td> #<\/p><\/td><\/tr> 7 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 8 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 9 years<\/p><\/td> #<\/p><\/td> #<\/p><\/td><\/tr> 10 years<\/p><\/td> 50<\/p><\/td> 40<\/p><\/td><\/tr> 10+ years<\/p><\/td> #<\/p><\/td> #<\/p><\/td><\/tr> Short Term Award<\/p><\/td> 10<\/p><\/td> 10<\/p><\/td><\/tr><\/tbody><\/table> Source: PIP ADS<\/p> Table 3: Enhanced PIP Daily living and Mobility component awards made between 1st<\/sup> November 2016 and 31st<\/sup> October 2017 with main disabling condition recorded as Parkinson\u2019s Disease<\/em><\/p> <\/p><\/td> (a) <\/strong>Enhanced Daily Living (may also have Enhanced Mobility)<\/strong><\/p><\/td> (b) <\/strong>Enhanced Mobility (may also have Enhanced Daily Living)<\/strong><\/p><\/td><\/tr> <\/p><\/td><\/tr> Total Awards<\/p><\/td> 2,310<\/p><\/td> 1,890<\/p><\/td><\/tr> Indefinite Award<\/p><\/td> 1,440<\/p><\/td> 1,400<\/p><\/td><\/tr> Finite Award<\/p><\/td> 870<\/p><\/td> 490<\/p><\/td><\/tr> Of which<\/p><\/td> <\/p><\/td> <\/p><\/td><\/tr> Less than 1 year<\/p><\/td> 20<\/p><\/td> 10<\/p><\/td><\/tr> 1 year<\/p><\/td> 30<\/p><\/td> 20<\/p><\/td><\/tr> 2 years<\/p><\/td> 270<\/p><\/td> 130<\/p><\/td><\/tr> 3 years<\/p><\/td> 310<\/p><\/td> 160<\/p><\/td><\/tr> 4 years<\/p><\/td> 100<\/p><\/td> 60<\/p><\/td><\/tr> 5 years<\/p><\/td> 100<\/p><\/td> 80<\/p><\/td><\/tr> 6 years<\/p><\/td> #<\/p><\/td> #<\/p><\/td><\/tr> 7 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 8 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 9 years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> 10 years<\/p><\/td> 30<\/p><\/td> 20<\/p><\/td><\/tr> 10+ years<\/p><\/td> 0<\/p><\/td> 0<\/p><\/td><\/tr> Short Term Award<\/p><\/td> 10<\/p><\/td> 10<\/p><\/td><\/tr><\/tbody><\/table> Source:PIP ADS<\/p> Notes for tables:<\/p> The information requested is not readily available and to provide it would incur disproportionate cost.<\/p> <\/strong><\/p> Detailed Reassessment Outcome statistics for Personal Independence Payment (PIP) can be found at:<\/p> <\/p><\/td> 2013<\/strong><\/p><\/td> 2014<\/strong><\/p><\/td> 2015<\/strong><\/p><\/td> 2016<\/strong><\/p><\/td> Total<\/strong><\/p><\/td><\/tr> Parkinson's disease<\/p><\/td> 0<\/p><\/td> 70<\/p><\/td> 420<\/p><\/td> 1,490<\/p><\/td> 1,980<\/p><\/td><\/tr> Multiple sclerosis<\/p><\/td> 0<\/p><\/td> 490<\/p><\/td> 1,950<\/p><\/td> 7,710<\/p><\/td> 10,160<\/p><\/td><\/tr> Motor neurone disease<\/p><\/td> 0<\/p><\/td> 40<\/p><\/td> 130<\/p><\/td> 190<\/p><\/td> 360<\/p><\/td><\/tr> Rheumatoid arthritis<\/p><\/td> 0<\/p><\/td> 1,130<\/p><\/td> 3,860<\/p><\/td> 9,930<\/p><\/td> 14,920<\/p><\/td><\/tr> Cystic fibrosis<\/p><\/td> 0<\/p><\/td> 40<\/p><\/td> 150<\/p><\/td> 460<\/p><\/td> 650<\/p><\/td><\/tr> Total<\/p><\/td> 0<\/p><\/td> 1,170<\/p><\/td> 6,510<\/p><\/td> 19,800<\/p><\/td> <\/p><\/td><\/tr><\/tbody><\/table> <\/p> October 2016 is the latest published data available. Later data is available but has been withheld as will be published as part of official statistics in December 2017.<\/p> We recognise that claimants in the ESA Support Group and UC Limited Capability for Work Related Activity with the most severe health conditions or disabilities who have conditions that are unlikely to improve, and are unlikely to ever be able to move closer to the labour market and into work, are having to go through a very lengthy, stressful and bureaucratic process to claim their benefits.<\/p> <\/p> We are working with our assessment provider, medical professionals and other stakeholders, to develop a set of criteria that will help us identify those with the most severe health conditions or disabilities, for whom ESA reassessments can be stopped unless there is a change of circumstances.<\/p> <\/p> Reviews of PIP are a key part of the benefit and ensure that not only awards remain correct where needs may change and that we also maintain contact with the claimant, both features missing from its predecessor Disability Living Allowance. PIP recognises that for the most severely disabled claimants, the award review process could seem unnecessarily intrusive. Existing PIP claimants with the most severe, lifetime disabilities, whose functional ability has remained the same, are more likely to have their evidence reviewed by a DWP Decision-Maker and will not need to have another face-to-face assessment with a healthcare professional.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4017", "label" : {"_value" : "Biography information for Penny Mordaunt"}
}
, "answeringMemberConstituency" : {"_value" : "Portsmouth North"}
, "answeringMemberPrinted" : {"_value" : "Penny Mordaunt"}
, "dateOfAnswer" : {"_value" : "2017-09-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-09-12T16:36:41.977Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "29"}
, "answeringDeptShortName" : {"_value" : "Work and Pensions"}
, "answeringDeptSortName" : {"_value" : "Work and Pensions"}
, "date" : {"_value" : "2017-09-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Personal Independence Payment: Medical Examinations"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Work and Pensions, how many completed repeat assessments there have been of people with (a) Parkinson's disease, (b) multiple sclerosis, (c) motor neurone disease, (d) rheumatoid arthritis and (e) cystic fibrosis, by year of repeat assessment, since the introduction of personal independence payments in 2013; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1490", "label" : {"_value" : "Biography information for Mrs Madeleine Moon"}
}
, "tablingMemberConstituency" : {"_value" : "Bridgend"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Madeleine Moon"}
], "uin" : "7144"}
, {"_about" : "http://data.parliament.uk/resources/756090", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/756090/answer", "answerText" : {"_value" : " The information requested is not readily available and to provide it would incur disproportionate cost.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4017", "label" : {"_value" : "Biography information for Penny Mordaunt"}
}
, "answeringMemberConstituency" : {"_value" : "Portsmouth North"}
, "answeringMemberPrinted" : {"_value" : "Penny Mordaunt"}
, "dateOfAnswer" : {"_value" : "2017-09-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-09-12T12:43:07.47Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "29"}
, "answeringDeptShortName" : {"_value" : "Work and Pensions"}
, "answeringDeptSortName" : {"_value" : "Work and Pensions"}
, "date" : {"_value" : "2017-09-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Social Security Benefits: Chronic Illnesses"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Work and Pensions, how many people with (a) cystic fibrosis, (b) rheumatoid arthritis, (c) motor neurone disease, (d) multiple sclerosis and (e) Parkinson's disease have qualified for (i) income-related employment and support allowance and (ii) income-related jobseeker's allowance since 2008; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1490", "label" : {"_value" : "Biography information for Mrs Madeleine Moon"}
}
, "tablingMemberConstituency" : {"_value" : "Bridgend"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Madeleine Moon"}
], "uin" : "7145"}
, {"_about" : "http://data.parliament.uk/resources/756091", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/756091/answer", "answerText" : {"_value" : " There were 30 female Jobseeker\u2019s Allowance claimants over the age of 60 in the county borough of Bridgend, which includes Porthcawl, as of July 2017.<\/p> <\/p> This information is published by NOMIS and available at https://www.nomisweb.co.uk/default.asp<\/a>> and can be accessed by choosing the Jobseekers Allowance Age and Duration dataset and selecting \u201clocal authorities: county / unitary (as of April 2015) (Oct 2004 onwards)\u201d, age, sex and date.<\/p> <\/p>